Historical price action around ESRT earnings shows moderate volatility, with an average absolute Day 0 move of 2.24% and Day +1 move of 2.91%. The Day 0 trading range averages 3.30%, expanding to 6.01% on Day +1 as the market fully processes results and guidance.
The pattern has been somewhat directionally mixed, with recent quarters showing both sharp declines (July 2025's 7.05% Day +1 drop, October 2025's 6.04% Day +1 decline) and more muted reactions. The most recent April 2026 report saw a relatively contained 1.92% Day 0 decline followed by a modest 0.89% Day +1 dip, suggesting investors may be growing more comfortable with the company's performance trajectory. Based on historical patterns, investors should anticipate a move in the 2-3% range on earnings day, with potential for wider swings depending on guidance and operational commentary.
| Metric | Value |
|---|---|
| Expiration Date | 08/21/26 (DTE 24) |
| Expected Move | $0.00 (0.00%) |
| Expected Range | $5.68 to $5.68 |
| Implied Volatility | 71.47% |
The options market is pricing in a 0.00% expected move for the August 21 expiration, which appears to be a data anomaly given the stock's historical earnings volatility averaging 2.24% on Day 0 and 2.91% on Day +1. With average volatility of 71.47% and minimal open interest of just 16 contracts, the options market for ESRT appears illiquid and may not be providing a reliable signal for this earnings event.
Analysts maintain a cautiously optimistic stance on ESRT with an average recommendation of 3.33 (between Hold and Buy), unchanged over the past month. The consensus includes 2 Strong Buys, 3 Holds, and 1 Strong Sell, reflecting divided opinions on the stock's prospects.
The mean price target of $6.35 implies approximately 12% upside from the current price of $5.66, with estimates ranging from a low of $5.75 to a high of $7.00. The sentiment trend is classified as unchanged, indicating analysts have not materially revised their views in recent weeks despite the stock's recent technical improvement.
The rating distribution suggests analysts see value in ESRT's Manhattan office portfolio and iconic assets, but remain cautious about near-term catalysts given the uncertain office market recovery and broader economic headwinds. The presence of one Strong Sell rating alongside two Strong Buys highlights the polarized views on whether the company's current valuation adequately reflects both its trophy asset quality and the structural challenges facing urban office REITs.
ESRT enters earnings with improving technical momentum after a period of weakness. The Barchart Technical Opinion has shifted from 100% Sell a month ago to 8% Sell last week, and now stands at 8% Buy, reflecting a notable reversal in short-term sentiment.
Timeframe Analysis:
Trend Characteristics: The Weak strength combined with Average direction suggests ESRT is in an early-stage recovery attempt that has not yet established conviction, creating an uncertain technical backdrop heading into earnings.
The stock is currently trading at $5.66, positioned above its 5-day ($5.57), 10-day ($5.61), 20-day ($5.56), 50-day ($5.49), and 100-day ($5.42) moving averages, but remains below the critical 200-day moving average of $6.10. This configuration shows short-term strength but highlights the significant overhead resistance that must be cleared to confirm a sustainable uptrend.
| Period | Value | Period | Value |
|---|---|---|---|
| 5-Day MA | $5.57 | 50-Day MA | $5.49 |
| 10-Day MA | $5.61 | 100-Day MA | $5.42 |
| 20-Day MA | $5.56 | 200-Day MA | $6.10 |
The 200-day moving average at $6.10 represents a key technical hurdle approximately 8% above current levels, aligning closely with the analyst consensus price target of $6.35. A strong earnings report that drives the stock through this level could trigger momentum-based buying, while disappointment could send ESRT back toward support in the $5.40-$5.50 range where the 50-day and 100-day averages reside. The technical setup is cautiously constructive but lacks the conviction of a strong trending environment, making the earnings release a potentially decisive catalyst for near-term direction.